← Leaderboards
Daniel Romo
Baylor University
$12,118,557
Attributed
$12,712,038
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $963.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,712,038 · 7
By mechanism
R01$6,059,028 · 4
R37$3,630,819 · 1
R35$2,329,797 · 1
R61$692,394 · 1
Top collaborators
- Zhong-Ping Feng2 shared
- Andrea Fleig2 shared
- F David Horgen2 shared
- Kenneth Gregory Hull2 shared
- Steven P Miller2 shared
- Hong-Shuo Sun2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBiologicalHuman DiseaseCellular BiologyMolecularInflammationComplexCellular TargetingLeadPoriferaProteinsCellsDesignCollaborationsBacterial InfectionsBiological FactorsRouteMarinesPathway InteractionsBaseCyclizationNew Therapeutic TargetSmall MoleculeInnovation
Grant awards (46)
Pharmacophore - Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies$446,414
R35 · FY2025 · GM · contact PI
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies$360,100
R35 · FY2024 · GM · contact PI
Development of the waixenicin A pharmacophore as a therapeutic intervention for neonatal hypoxic brain injury$319,516
R61 · FY2024 · NS · contact PI
Development of the waixenicin A pharmacophore as a therapeutic intervention for neonatal hypoxic brain injury$372,878
R61 · FY2023 · NS · contact PI
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies$360,100
R35 · FY2023 · GM · contact PI
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies$390,100
R35 · FY2022 · GM · contact PI
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies$399,725
R35 · FY2021 · GM · contact PI
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies$99,788
R35 · FY2021 · GM · contact PI
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies$273,570
R35 · FY2020 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$233,059
R37 · FY2019 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$339,513
R37 · FY2018 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$339,513
R37 · FY2017 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$332,099
R37 · FY2016 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$323,900
R37 · FY2015 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$377,972
R37 · FY2014 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$322,460
R37 · FY2013 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$338,366
R37 · FY2012 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$341,781
R37 · FY2011 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$350,069
R37 · FY2010 · GM · contact PI
New Methods for Simultaneous Arming and SAR Studies of Natural Products$328,275
R01 · FY2010 · GM · contact PI
b-Lactones: Bioactive Target and Vehicles for Synthesis$285,454
R01 · FY2010 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$332,087
R37 · FY2009 · GM · contact PI
New Methods for Simultaneous Arming and SAR Studies of Natural Products$324,315
R01 · FY2009 · GM · contact PI
b-Lactones: Bioactive Target and Vehicles for Synthesis$300,551
R01 · FY2009 · GM · contact PI
New Methods for Simultaneous Arming and SAR Studies of Natural Products$377,447
R01 · FY2008 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$272,472
R01 · FY2008 · GM · contact PI
New Methods for Simultaneous Arming and SAR Studies of Natural Products$219,999
R01 · FY2008 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$272,472
R01 · FY2007 · GM · contact PI
B-Lactones: Bioactive Target and Vehicles for Synthesis$217,289
R01 · FY2007 · GM · contact PI
NOVEL ANTICANCER FATTY ACID SYNTHASE INHIBITORS$209,616
R01 · FY2007 · CA · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$280,610
R01 · FY2006 · GM · contact PI
B-Lactones: Bioactive Target and Vehicles for Synthesis$223,778
R01 · FY2006 · GM · contact PI
NOVEL ANTICANCER FATTY ACID SYNTHASE INHIBITORS$217,077
R01 · FY2006 · CA · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$41,172
R01 · FY2006 · GM · contact PI
Synthetic/Mechanistic Studies of Bioactive Marine Agents$287,363
R01 · FY2005 · GM
NOVEL ANTICANCER FATTY ACID SYNTHASE INHIBITORS$241,749
R01 · FY2005 · CA
B-Lactones: Bioactive Target and Vehicles for Synthesis$229,163
R01 · FY2005 · GM
B-Lactones: Bioactive Target and Vehicles for Synthesis$241,425
R01 · FY2004 · GM
NOVEL ANTICANCER FATTY ACID SYNTHASE INHIBITORS$241,017
R01 · FY2004 · CA
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS$9,283
R01 · FY2004 · GM
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS$261,314
R01 · FY2003 · GM
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS$54,194
R01 · FY2003 · GM
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS$277,496
R01 · FY2002 · GM
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS$296,644
R01 · FY2001 · GM
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS$33,005
R01 · FY2001 · GM
SYNTHETIC/MECHANISTIC STUDIES OF BIOACTIVE MARINE AGENTS$315,848
R01 · FY2000 · GM